RSS Items

Obesity treatment CagriSema misses goal of 25% reduction in body weight

Danish manufacturer Wegovy invests in two start-ups as part of efforts to stay ahead in major new market

Drugmakers claim that Brussels’ market exclusivity overhaul will reduce R&D investment

Chief executive says customers very willing to pay for Wegovy from their own pockets

Market will never be winner takes all given that different patients will have different requirements

Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group

Danish drugmaker’s second-quarter sales and profits fall short of forecasts

Danish group has expanded manufacturing capacity but says demand will continue to outstrip supply

Danish drugmaker reports better than expected sales and profits for 2023

Group looks to more friendly markets for growth after US crackdown